Tandem Diabetes Care Inc (TNDM)
43.47
-1.25
(-2.80%)
USD |
NASDAQ |
May 06, 16:00
43.47
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Free Cash Flow: -83.41M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -83.41M |
| September 30, 2023 | -48.52M |
| June 30, 2023 | -41.28M |
| March 31, 2023 | -30.80M |
| December 31, 2022 | 7.512M |
| September 30, 2022 | 21.21M |
| June 30, 2022 | 50.36M |
| March 31, 2022 | 73.84M |
| December 31, 2021 | 87.85M |
| September 30, 2021 | 85.10M |
| June 30, 2021 | 61.77M |
| March 31, 2021 | 44.93M |
| December 31, 2020 | -7.625M |
| September 30, 2020 | -6.072M |
| June 30, 2020 | 4.601M |
| March 31, 2020 | 0.50M |
| December 31, 2019 | 22.36M |
| September 30, 2019 | 22.92M |
| June 30, 2019 | 0.052M |
| March 31, 2019 | -4.051M |
| December 31, 2018 | -11.30M |
| Date | Value |
|---|---|
| September 30, 2018 | -37.61M |
| June 30, 2018 | -52.40M |
| March 31, 2018 | -61.18M |
| December 31, 2017 | -71.85M |
| September 30, 2017 | -75.12M |
| June 30, 2017 | -76.15M |
| March 31, 2017 | -75.67M |
| December 31, 2016 | -70.10M |
| September 30, 2016 | -65.69M |
| June 30, 2016 | -61.48M |
| March 31, 2016 | -66.40M |
| December 31, 2015 | -64.60M |
| September 30, 2015 | -66.97M |
| June 30, 2015 | -65.44M |
| March 31, 2015 | -63.30M |
| December 31, 2014 | -65.96M |
| September 30, 2014 | -65.98M |
| June 30, 2014 | -65.00M |
| March 31, 2014 | -62.31M |
| December 31, 2013 | -53.77M |
Free Cash Flow Range, Past 5 Years
-83.41M
Minimum
Dec 2023
87.85M
Maximum
Dec 2021
13.96M
Average
7.512M
Median
Dec 2022
Free Cash Flow Benchmarks
| Insulet Corp | 36.50M |
| Stryker Corp | 2.858B |
| Abbott Laboratories | 5.059B |
| Integer Holdings Corp | 72.95M |
| Twist Bioscience Corp | -95.52M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.216M |
| Cash from Investing (Quarterly) | -16.58M |
| Cash from Financing (Quarterly) | 2.617M |
| Free Cash Flow Per Share (Quarterly) | -0.5308 |
| Free Cash Flow to Equity (Quarterly) | -35.15M |
| Free Cash Flow to Firm (Quarterly) | -34.70M |
| Free Cash Flow Yield | -2.95% |